Dillard's (DDS)
(Delayed Data from NYSE)
$434.00 USD
+2.70 (0.63%)
Updated May 3, 2024 04:00 PM ET
After-Market: $433.64 -0.36 (-0.08%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$434.00 USD
+2.70 (0.63%)
Updated May 3, 2024 04:00 PM ET
After-Market: $433.64 -0.36 (-0.08%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth A Momentum A VGM
Zacks News
Dillard's (DDS) Stock Gains on Q2 Earnings & Sales Beat
by Zacks Equity Research
Dillard's (DDS) Q2 results gain from continued strong consumer demand. However, inflationary pressure remains concerning.
Dillard's (DDS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Dillard's (DDS) delivered earnings and revenue surprises of 222.92% and 2.23%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's How Dillard's (DDS) is Placed Just Ahead of Q2 Earnings
by Zacks Equity Research
Dillard's (DDS) Q2 results are expected to reflect gains from strong consumer demand and inventory management amid rising SG&A expenses and supply-chain costs.
Earnings Preview: Dillard's (DDS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Dillard's (DDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 2nd
by Zacks Equity Research
DDS, BRY, and MTZ have been added to the Zacks Rank #5 (Strong Sell) List on August 2, 2022.
Gap (GPS) to Open 2 Athleta Stores as Part of Its Growth Strategy
by Zacks Equity Research
Gap's Athleta brand is set to open two outlet stores as part of its store fleet strategy. The move is likely to attract new customers and help increase brand awareness.
Gap (GPS), Reliance Retail Partner to Woo Customers in India
by Zacks Equity Research
Gap (GPS) makes yet another attempt to attract customers in India by signing a franchise agreement with Reliance Retail. This will help expand its base across key international markets.
Zacks.com featured highlights include Dillard, Antero Resources, and Delek US Holdings
by Zacks Equity Research
Dillard, Antero Resources, and Delek US Holdings are part of the Zacks Screen of the week article.
3 Stocks With Momentum Anomaly to Buy Amid Downturn Concerns
by Supriyo Bose
Dillard's (DDS), Antero Resources (AR) and Delek US Holdings (DK) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Kohl's (KSS) Stock Crashes on Strategic Review Update, View Cut
by Zacks Equity Research
Kohl's Corporation (KSS) decides to end its strategic review process with Franchise Group due to the existing retail and financial landscape. It also cuts the sales growth view for the second quarter.
Bed Bath & Beyond (BBBY) Q1 Earnings & Sales Lag, Stock Dips
by Zacks Equity Research
Bed Bath & Beyond's (BBBY) Q1 results have been hurt by challenging macroeconomic scenarios, a shift in consumer spending and supply-chain issues. Also, it makes significant leadership changes.
Walmart's (WMT) Memomi Buyout to Fuel Health & Wellness Mission
by Zacks Equity Research
Walmart (WMT) to acquire an augmented reality optical tech company, Memomi. Management expects to conclude the acquisition in the coming weeks.
Are Options Traders Betting on a Big Move in Dillard's (DDS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Dillard's (DDS) stock based on the movements in the options market lately.
Zacks.com featured highlights include Dillard, Avis Budget Group, Wyndham Hotels & Resorts, and American International Group
by Zacks Equity Research
Dillard, Avis Budget Group, Wyndham Hotels & Resorts, and American International Group are part of Zacks screen of the week article.
Here's Why Ulta Beauty (ULTA) Appears to be a Promising Pick
by Zacks Equity Research
Ulta Beauty (ULTA) has been benefiting from its strong omnichannel business and skincare category growth.
4 Stocks That Boast Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Dillard's (DDS), Avis Budget (CAR), Wyndham Hotels (WH) and American International Group (AIG) are sound enough to meet financial obligations.
Zacks.com featured highlights include Louisiana-Pacific, Coca-Cola, Qualcomm, Matson and Dillard's
by Zacks Equity Research
Louisiana-Pacific, Coca-Cola, Qualcomm, Matson and Dillard's are part of Screen of the Week article.
Newell (NWL) Looks Well-Placed on Strong Demand & Innovation
by Zacks Equity Research
Newell (NWL) looks promising on the back of robust demand, product innovation and solid online show despite inflation and supply-chain headwinds.
Strength Seen in Macy's (M): Can Its 9.9% Jump Turn into More Strength?
by Zacks Equity Research
Macy's (M) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Rite Aid (RAD) Q1 Loss Narrower Than Expected, Revenues Beat
by Zacks Equity Research
Rite Aid's (RAD) Q1 results gain from higher sales of non-COVID-19 prescriptions and continued momentum at Elixir. Management raises its revenue guidance for fiscal 2023.
Bet on 5 Stocks With High ROE to Trounce Recession Fears
by Supriyo Bose
Louisiana-Pacific Corporation (LPX), Coca-Cola (KO), Qualcomm (QCOM), Matson (MATX) and Dillard's (DDS) are some of the stocks with high ROE to profit and trump recessionary concerns.
Walmart (WMT) Down More Than 10% in 3 Months: Here's Why
by Zacks Equity Research
Walmart (WMT) is grappling with supply0chain hurdles, escalated costs and persistently elevated inflation.
Gap's (GPS) Althleta Brand Expands in Canada With Five Stores
by Zacks Equity Research
Gap's (GPS) Athleta brand expands in Canada with five stores. Also, its Old Navy brand is all set to enter the metaverse.
Here's Why You Should Hold on to Tractor Supply (TSCO) Stock
by Zacks Equity Research
Tractor Supply (TSCO) remains well-poised on the back of online strength, solid demand and other growth efforts despite inflation and supply-chain woes.
Is Dillard's (DDS) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Here is how Dillard's (DDS) and Dollar Tree (DLTR) have performed compared to their sector so far this year.